Autoimmune Diseases
Welcome,         Profile    Billing    Logout  
 293 Companies   490 Products   490 Products   199 Mechanisms of Action   25 Trials   7787 News 


«12...5051525354555657585960...156157»
  • ||||||||||  Truxima (rituximab-abbs) / Indukern, Teva, Mundipharma, Celltrion, Nippon Kayaku
    Trial completion:  Long-Term Efficacy and Safety of CT-P10 in Patients With RA (clinicaltrials.gov) -  Nov 27, 2015   
    P1,  N=87, Completed, 
    Active, not recruiting --> Completed
  • ||||||||||  Enrollment open:  CLaRA: Curcuma Longa L in Rheumatoid Arthritis (clinicaltrials.gov) -  Nov 27, 2015   
    P1,  N=45, Recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Recruiting
  • ||||||||||  dalfampridine / Generic mfg.
    Trial initiation date, Trial termination, Trial primary completion date:  Fampridine Pregnancy Exposure Registry (clinicaltrials.gov) -  Nov 25, 2015   
    P=N/A,  N=375, Terminated, 
    Not yet recruiting --> Recruiting Initiation date: Dec 2015 --> Aug 2015 | Recruiting --> Terminated | Trial primary completion date: Oct 2020 --> Dec 2015; Due to low enrollment, registration closed in agreement with the Regulatory Agency
  • ||||||||||  Humira (adalimumab) / Eisai, AbbVie
    Trial completion, Enrollment change:  Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice (clinicaltrials.gov) -  Nov 25, 2015   
    P=N/A,  N=445, Completed, 
    Initiation date: Dec 2015 --> Aug 2015 | Recruiting --> Terminated | Trial primary completion date: Oct 2020 --> Dec 2015; Due to low enrollment, registration closed in agreement with the Regulatory Agency Active, not recruiting --> Completed | N=1000 --> 445
  • ||||||||||  dimethyl fumarate / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date, Adverse events:  Tecfidera Slow-titration Study (clinicaltrials.gov) -  Nov 24, 2015   
    P3,  N=62, Terminated, 
    Active, not recruiting --> Completed N=300 --> 62 | Recruiting --> Terminated | Trial primary completion date: Mar 2017 --> Dec 2015; Sponsor decision
  • ||||||||||  Enrollment open, Trial primary completion date:  BARDA II: Identify Clinical Conditions That Increase Circulating DNA Levels (clinicaltrials.gov) -  Nov 22, 2015   
    P=N/A,  N=130, Recruiting, 
    Completed --> Terminated; Cancelled due to low enrollment Suspended --> Recruiting | Trial primary completion date: Sep 2015 --> Sep 2017
  • ||||||||||  icanbelimod (CBP-307) / Suzhou Connect Biopharma
    Enrollment closed:  Phase 1 Study Accessing the Safety and Tolerability of CBP-307 (clinicaltrials.gov) -  Nov 21, 2015   
    P1,  N=64, Active, not recruiting, 
    Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting
  • ||||||||||  New trial:  Accu-Chek (clinicaltrials.gov) -  Nov 21, 2015   
    P=N/A,  N=200, Not yet recruiting, 
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen
    Trial primary completion date:  Study to Observe the Safety and Efficacy of Etanercept (Enbrel (clinicaltrials.gov) -  Nov 19, 2015   
    P=N/A,  N=120, Recruiting, 
    Trial primary completion date: Sep 2015 --> Dec 2015 Trial primary completion date: Sep 2015 --> Aug 2016
  • ||||||||||  Trial primary completion date:  Closing the Loop 24/7 in Adolescents With Type 1 Diabetes (clinicaltrials.gov) -  Nov 17, 2015   
    P=N/A,  N=24, Active, not recruiting, 
    Trial primary completion date: Aug 2015 --> Aug 2016 Trial primary completion date: Sep 2015 --> Jan 2016
  • ||||||||||  Trial completion:  The CARRA Registry (clinicaltrials.gov) -  Nov 17, 2015   
    P=N/A,  N=9587, Completed, 
    Trial primary completion date: Feb 2014 --> Dec 2015 Enrolling by invitation --> Completed
  • ||||||||||  dimethyl fumarate / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  INSPIRE: BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis (clinicaltrials.gov) -  Nov 16, 2015   
    P3,  N=58, Terminated, 
    Active, not recruiting --> Terminated; The ASCEND Study did not achieve statistical significance on the primary or secondary endpoints. N=1170 --> 58 | Recruiting --> Terminated | Trial primary completion date: Jun 2019 --> Feb 2016; Sponsor Decision
  • ||||||||||  Trial primary completion date:  Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diab (clinicaltrials.gov) -  Nov 16, 2015   
    P2,  N=36, Recruiting, 
    N=1170 --> 58 | Recruiting --> Terminated | Trial primary completion date: Jun 2019 --> Feb 2016; Sponsor Decision Trial primary completion date: Oct 2015 --> Mar 2016
  • ||||||||||  PF530 (interferon beta-1b biosimilar) / Ligand
    Trial completion:  Comparison Study of PF530 and Betaferon in Healthy Subjects (clinicaltrials.gov) -  Nov 16, 2015   
    P1,  N=12, Completed, 
    Not yet recruiting --> Recruiting Active, not recruiting --> Completed
  • ||||||||||  leucovorin calcium / Generic mfg.
    Trial termination, Trial primary completion date:  A Folinic Acid Intervention for Autism Spectrum Disorders (clinicaltrials.gov) -  Nov 15, 2015   
    P2,  N=160, Terminated, 
    Active, not recruiting --> Completed Suspended --> Terminated | Trial primary completion date: Sep 2017 --> Jun 2015; Non-compliance
  • ||||||||||  DegludecPlus (insulin degludec/insulin aspart) / Novo Nordisk
    Trial initiation date, Trial primary completion date:  Post Marketing Surveillance (PMS) Study of Ryzodeg (clinicaltrials.gov) -  Nov 14, 2015   
    P=N/A,  N=1000, Not yet recruiting, 
    Recruiting --> Active, not recruiting Initiation date: Apr 2015 --> Dec 2015 | Trial primary completion date: Mar 2016 --> Sep 2017
  • ||||||||||  Trial primary completion date:  CLaRA: Curcuma Longa L in Rheumatoid Arthritis (clinicaltrials.gov) -  Nov 14, 2015   
    P1,  N=45, Not yet recruiting, 
    Initiation date: Apr 2015 --> Dec 2015 | Trial primary completion date: Mar 2016 --> Sep 2017 Trial primary completion date: Jan 2017 --> Jun 2017